14 November 2017

Newcross raising awareness for World Diabetes Day

World Diabetes Day

Newcross Healthcare is raising awareness of Diabetes as part of World Diabetes Day

Many of Newcross Healthcare’s nurses and carers work with service users living with the condition and are expected to identify any early indicators of physical deterioration linked to the condition and report these promptly to the appropriate person(s). As well as that they should recognise an emergency related to diabetes, such as a hypoglycemic event, and respond swiftly and competently.

Over 382 million people worldwide suffer from the condition, that's 1 in every 16 people having diabetes (diagnosed and undiagnosed).

Diabetes occurs when the amount of glucose in the blood is too high due to the body being unable to process it properly. Serious health implications can develop if left untreated.

There are two distinct types of diabetes which are explained below, however, a recent study by the American Diabetes Association unveiled the existence of a third type named Type 3c for which research is still ongoing.

Type 1

It is an autoimmune condition where the body attacks and destroys insulin-producing cells, thereby causing no insulin to be produced.

The main symptoms of Type 1 diabetes are:

  • Excessive thirst
  • Tiredness
  • Frequent urination
  • Unexplained weight loss

Type 2

It is a metabolic disorder that is characterised by the body being unable to metabolise glucose, thereby resulting in high levels of blood glucose. This causes hyperglycemia (high glucose levels) due to the body being ineffective at using the insulin that it produces and/or being unable to produce enough insulin.

The main symptoms of Type 2 diabetes are:

  • Excessive thirst
  • Frequent urination
  • Increased hunger
  • Extreme tiredness
  • Sudden loss of muscle mass

Research funded by the national charity Diabetes UK has been geared towards developing and approving an artificial pancreas for adults with Type 1 diabetes. The artificial pancreas is a system that measures blood glucose levels on a minute-to-minute basis using a continuous glucose monitor (CGM), this information is then transmitted to an insulin pump that calculates and release the required amount of insulin into the body. The artificial pancreas is still undergoing clinical trials and is not currently available.

For more information, you can read and/or download Newcross Healthcare’s Diabetes policy here or refer to your local Newcross Lead Nurse if you need further support, training or guidance as needed.